“Study of the use of zoledronic acid in pediatric patients with osteogenesis imperfecta at the Fernandes Figueira Institute (IFF/Fiocruz)” (2026) Research, Society and Development, 15(1), p. e0615150474. doi:10.33448/rsd-v15i1.50474.